300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Taiwan
Egypt
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Zimbabwe
Tunisia
Sweden
Oceania
Oman
Poland
Puerto Rico
Colombia
Cameroon
Guernsey
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Namibia
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

China Science and Technology Innovation

VC Fund

China Science and Technology Innovation is a VC fund focused on Manufacturing and Energy. China Science and Technology Innovation operates as an investment firm.

Total investments:
10
Last investment:
Lead investor:
10%

Last updated:

Industries China Science and Technology Innovation invests in

ManufacturingEnergyElectronicsBiotechnologySemiconductor

Stages China Science and Technology Innovation invests in

Series ASeedSeries BAngelSeries C

Countries China Science and Technology Innovation invests in

ChinaJapan

Round sizes

Seed $15M–$16MSeries A $31M–$251MSeries B $31M–$251M

Round size

Seed
$15M–$16M
Series A
$31M–$251M
Series B
$31M–$251M

Investment Focus

Industry

  • Manufacturing 3 (30%)
  • Energy 2 (20%)
  • Electronics 2 (20%)
  • Biotechnology 2 (20%)
  • Semiconductor 2 (20%)
See all 16 industries →

Stage

  • Series A 4 (40%)
  • Seed 2 (20%)
  • Series B 2 (20%)
  • Angel 1 (10%)
  • Series C 1 (10%)

Country

  • China 9 (90%)
  • Japan 1 (10%)

Investments

CompanyDescriptionRoundLinks
Kaixinhong
RedRISC is a cutting edge semiconductor enterprise focused on high end chip design services and open source hardware ecosystems. Operating as the dedicated industrialization and commercial platform for the Beijing Open Source Chip Research Institute, the company leverages the high profile Xiangshan open source processor architecture to develop highend computing solutions. $14.8M / Seed / Aug 11, 2026
Bengbengyu is a freshwater fish breeding manufacturer that engages in product nursery, breeding, and processing of aquatic products. Series A / May 15, 2024
Zhaohuang New Energy Zhaohuang New Energy
Zhaohuang New Energy manufactures metal lithium anode products that are used in the used in the fields of next-generation solid-state lithium batteries, lithium-sulfur batteries, and lithium-air batteries. Angel / Jul 17, 2023
Yanming Biology Yanming Biology
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors. $96.8M / Series A / Jul 10, 2023
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples inbiosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad. Series C / Jan 12, 2023
Gokin Solar
Guangdong Gaojing Solar Energy Technology is a solar energy technology. $251.2M / Series A / Apr 13, 2022
Xinling Pharmaceutical is an innovative transdermal preparation platform company. $15.7M / Seed / Mar 18, 2022
NewRadioTech focuses on the silicon and system solutions for wireless communication and positioning systems. $31.4M / Series A / Jan 29, 2022
Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing. $251M / Series B / Dec 20, 2021
Akon health is an operation and management organization of prescription drugs for chronic diseases, which integrates prescription drug management, chronic disease management, hospital prescription circulation, e-commerce operation, and out-of-hospital prescription increment. It focuses on providing pharmaceutical service and care for patients withchronic diseases who leave the hospital, and providing channel expansion, product increment, and patient data management of out-of-hospital prescription drugs for pharmaceutical enterprises. $30.7M / Series B / Mar 17, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Taiwan
Egypt
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Zimbabwe
Tunisia
Sweden
Oceania
Oman
Poland
Puerto Rico
Colombia
Cameroon
Guernsey
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Namibia
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does China Science and Technology Innovation invest in?

China Science and Technology Innovation invests primarily in Manufacturing, Energy and Electronics startups, most often at Series A and Seed stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is China Science and Technology Innovation's check size?

China Science and Technology Innovation typically joins rounds of $15M–$16M at Seed, $31M–$251M at Series A and $31M–$251M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds China Science and Technology Innovation participates in.

When did China Science and Technology Innovation last invest?

The most recent investment recorded for China Science and Technology Innovation closed in Aug 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
China Science and Technology Innovation Find emails